Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1B Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor
Position
Chief Executive Officer
Company
Incendia Therapeutics
CambridgeBiotechnologyHealth CareMedicalTherapeuticsDescription
Incendia Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment , today announced the appointment of Wendye Robbins, M.D., as Chief Executive Officer.
Quick answer
Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1B Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor (November 13, 2023). Incendia Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Executive Officer at Incendia Therapeutics?
- Incendia Therapeutics named Wendye Robbins Chief Executive Officer, announced November 13, 2023.
- What did Incendia Therapeutics announce on November 13, 2023?
- Incendia Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment , today announced the appointment of Wendye Robbins, M.D., as Chief Executive Officer.
- What does Incendia Therapeutics do?
- Incendia Therapeutics is discovering and developing novel anti-cancer medicines that are designed to reprogram the tumor microenvironment.
- Where is Incendia Therapeutics based?
- Incendia Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Aethlon Medical (November 13, 2023), Genentech (November 7, 2023), OncoNano Medicine (November 6, 2023) and Diakonos Oncology (November 20, 2023) also announced leadership changes within 45 days of Incendia Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
- Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech (November 7, 2023)
- OncoNano Medicine Announces Promotion of Kartik Krishnan, MD, PhD, to President and Head of Research & Development (November 6, 2023)
- Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer (November 20, 2023)
- BioMarin Announces Retirement of Jean-Jacques Bienaimé; Appoints Alexander Hardy President and Chief Executive Officer (November 1, 2023)
- Corcept Appoints Monica Tellado as President, Emerging Markets (November 1, 2023)
Who to call at Incendia Therapeutics, and when
A new leader at Incendia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Incendia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Incendia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Incendia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Incendia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Incendia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.